Biotech startup AUM Biosciences announced on Tuesday it has raised $27 million (around Rs 200 crore) in a Series A funding round from Singapore-based private equity fund Everlife and SPRIM Global ...

Singapore: AUM Biosciences (AUM) today announced the completion of a $27 million series A funding round which will help them in achieving their drug targets and address the need to delay and overcome ...

New Delhi: Everstone-backed Everlife, a distributor and manufacturer of medical and laboratory equipment and devices in Asia on Wednesday announced the appointment of Raman Gandotra as its new CEO.

In-vitro diagnostic (IVD) products manufacturer, CPC Diagnostics Pvt Ltd has acquired the i-chroma brand business of South Korea-based company, Boditech Med Inc from Weldon Biotech India Pvt. Ltd for ...

Singapore-based private equity firm Everstone Capital is evaluating various exit options for two healthcare companies in its portfolio, Translumina Therapeutics and Everlife Holdings, with an initial ...

The group did not disclose the stake it acquired or the transaction cost but pointed out that it bought a controlling stake. (website) Everstone Group said on Wednesday its healthcare platform ...

The Everstone Group through its healthcare platform Everlife has acquired a stake in Chennai-based CPC Diagnostics, to include core in-vitro diagnostics (IVD) segments in its portfolio of medical ...

Hillhouse vying for Everstone's $1 bln Asia health services firm Everlife - sources Global investment firm Hillhouse is emerging as one of the final few bidders for Everlife Holdings in a deal that ...

HONG KONG/SINGAPORE, Oct 30 (Reuters) - Singapore-headquartered private equity firm Everstone Capital has hired BDA Partners to run a sale of Everlife Holdings that could value the healthcare services ...